BIOSECURE Act
Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?
Pharma's Almanac
PAO-11-24-RT-01Oct 28, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01Aug 07, 2024
Digitalization
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
Pharma's Almanac
PAO-06-24-RT-02Jun 24, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02Mar 08, 2024
Roundtable
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
Pharma's Almanac
PAO-12-23-RT-02Dec 15, 2023
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Pharma's Almanac
PAO-12-23-RT-01Dec 14, 2023
RNA
Closing the Developability Gap for RNA Therapeutics and Vaccines with a Fit-for-Purpose Analysis Kit
Susan Darling; Quincy Mehta
SCIEX
PAO-07-022-CL-06Jul 19, 2022
RNA Analysis Kit Launch
RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics
SCIEX
PR-M05-22-09May 16, 2022